KMS Medisurgi Share Price
132.80+0.00 (+0.00%)
+4.98% past 1 Year
KMS Medisurgi manufactures and undertakes job work of coating of various substrates like non woven fabrics PU films cotton fabrics and taffeta silk fabrics with adhesive. They are engaged into
Corporate filings & documents
Announcements
KMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on Saturday 5th September 2026
1 week agoKMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on Saturday 5th September 2026
1 week agoNon applicability of report on corporate governance pursuant to regulation 27(2) of the SEBI (Listing obligation and disclosure requirements) Regulation 2015.
1 month agoNon applicability of report on corporate governance pursuant to regulation 27(2) of the SEBI (Listing obligation and disclosure requirements) Regulation 2015.
1 month agoCertificate under Regulation 74(5) of SEBI(DP) Regulation 2018
1 month agoCertificate under Regulation 74(5) of SEBI(DP) Regulation 2018
1 month agoSubmission of Standalone audited financial results for the year ended 31 March 2026
3 months agoSubmission of Standalone Audited financial result for the year ended 31.03.2026.
3 months agoKMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve This is to inform you that pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the Board of Directors of KMS Medisurgi Limited (the Company) will be held on Saturday May 30 2026 at 02.00 pm at the Registered office of the Company situated at 297/301 Ground Fioor May Building Princess Street Marine Lines (East) Mumbai 400 002 inter-alia to consider and approve:1) Standalone Audited financial results for the year ended March 31 2026.2) Any other agenda with the permission of chairman.
3 months agoKMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve This is to inform you that pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 a meeting of the Board of Directors of KMS Medisurgi Limited (the Company) will be held on Saturday May 30 2026 at 02.00 pm at the Registered office of the Company situated at 297/301 Ground Fioor May Building Princess Street Marine Lines (East) Mumbai 400 002 inter-alia to consider and approve:1) Standalone Audited financial results for the year ended March 31 2026.2) Any other agenda with the permission of chairman.
3 months agoMeeting of the Board of Directors of the company will be held on Saturday May 30 2026 at 02.00 pm at the registered office of the company.
3 months agoMeeting of the Board of Directors of the company will be held on Saturday May 30 2026 at 02.00 pm at the registered office of the company.
3 months agoMr. Pratik Pravin Tarpara has ceased to be an Independent Director of the company w.e.f. 30th September 2025 upon completion of his tenure.
3 months agoMr. Pratik Pravin Tarpara has ceased to be an Independent Director of the company w.e.f. 30th September 2025 upon completion of his tenure.
3 months agoNon applicability of Regulation 24A of SEBI (LODR) Regulation 2015.
4 months agoNon applicability of report on CG.
4 months agoNon applicability of report on CG.
4 months agoNon applicability of Disclosure of related party transactions.
4 months agoNon applicability of Disclosure of related party transactions.
4 months agoCertificate under Regulation 74(5) of the SEBI (DP) Regulations 2018.
4 months agoCertificate under Regulation 74(5) of the SEBI (DP) Regulations 2018.
4 months agoClosure of Trading Window
5 months agoNon applicability of CG report
7 months agoCertificate under regulation 74(5) of SEBI (DP) Regulation 2018.
7 months agoNon applicability of related party transaction
9 months agoSubmission of Unaudited financial results for the Half year ended September 30 2025
9 months agoBoard of Directors of the company at its meeting held by today have inter alia considered approved and taken on record the unaudited standalone financial statement of the company for the half year ended 30th September 2025
9 months agoKMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve This is to inform you that Pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday November 14 2025 at 1:00 pm at the registered office of the Company to consider and approve:1. The Un-Audited Financial Results of the Company for the half year ended 30th September 2025 and the Limited review report thereon;2. Any other items if any Further in terms of Companys Code of Conduct for Prevention of insider Trading the closure of trading window for purchase/sale of securities of the Company by the Designated persons and their immediate relatives has already commenced from October 1 2025 and will end Forty-Eight (48) hours after the declaration of Financial Results of the Company for the Half year ended on 30th September 2025.
10 months agoCertificate under regulation 74(5) of SEBI DP Regulation 2018
10 months agoCompany has listed its share on BSE SME Platform hence corporate governance is not applicable.
11 months agoVoting result along with Consolidated Scrutinizer report of 27th AGM.
11 months agoProceedings of 27th Annual General Meeting
11 months agoIntimation of closure of trading window under SEBI (Prohibition of Insider Trading) Regulation 2015.
11 months agoPursuant to Regulation 34(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we are submitting herewith the Annual Report of the Company for the FY 2024-25.
12 months agoRecord date for payment of dividend
12 months agoPayment of Dividend
12 months agoBoard of Directors have recommended Final Dividend of Rs. 0.05 (0.5%) Per equity share for the year ended 31st March 2025 subject to the approval of shareholders.
12 months agoBoard of Directors recommended Final Dividend of Rs. 0.05 (0.5%) per equity shares for the year ended 31st March 2025 subject to approval of shareholders.
12 months agoNotice is hereby given that the 27th Annual General Meeting of the company will be held on Tuesday September 30th 2025 at 3 pm at the registered office of the company.
12 months agoOutcome of Board meeting held on Thursday 04th September 2025
12 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2025-09-23
Dividend
0.05
2024-09-23
Dividend
0.05
2023-09-22
Dividend
0.05
Company details
Registered office
297/301 May Building, Ground Floor Princess Street Marine Lines (East) Mumbai Maharashtra PIN: 400002 Tel No: 022-66107700 / 22 / 67498822 Fax No: 022-22061111 Email: [email protected] Internet: www.kmsgroup.in
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Siddharth Kanakia, Chairman & Managing Director
Siddharth Kanakia, Chairman & Managing Director
Rohan Devang Kanakia, Non Independent & Non Executive Director
Monali Kanakia, Executive Director
Gaurang Prataprai Kanakia, Non Independent & Non Executive Director
Hardik Rajnikant Bhatt, Non Executive Independent Director
Kamlesh Chunilal Rajani, Non Executive Independent Director
Pratik Pravin Tarpara, Non Executive Independent Director
Pooja Soni, Company Secretary & Compliance Officer
Details
BSE 540468
NSE NULL
ISIN INE870V01014